Please login to the form below
rheumatology
This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.
Novartis’ Cosentyx misses the mark in Humira head-to-head
Novartis continues to reimagine care for patients and advance science in rheumatology.
Latest news
-
GSK pushes rheumatoid arthritis antibody into phase 3
It has taken the decision to push otilimab into phase 3 on the strength of the mid-stage BAROQUE trial, which was reported at the American College of Rheumatology (ACR) congress
-
FDA clears Dupixent as first-ever drug for chronic rhinosinusitis with nasal polyps
Nasal polyps can lead to loss of smell and often patients require surgery to remove the polyps,” said the agency’s head of pulmonary, allergy and rheumatology products Sally Seymour.
-
AbbVie’s upadacitinib tops Humira again in arthritis trial
The lead investigator in the SELECT-EARLY trial, Prof Ronald van Vollenhoven of the Amsterdam Rheumatology and Immunology Centre in the Netherlands, said that while remission is the primary treatment goal
-
Novartis forges AI alliance with Oxford University
It says the Oxford University alliance will be “transformative for how Novartis adopts data science at scale from multiple data sources, beginning with flagship programmes in multiple sclerosis, dermatology and rheumatology.”
-
US ‘unicorn’ Samumed on track with lead arthritis drug
The San Diego company presented data at this week’s American College of Rheumatology (ACR) meeting showing that a single injection of SM04690 into the joints of people with OA of
More from news
Approximately 1 fully matching, plus 73 partially matching documents found.
Latest Intelligence
-
Virtual congresses: video thrilled the cardio tsar
Its application to major congresses across all medical disciplines – from cancer to cardiovascular, respiratory to rheumatology – will undoubtedly continue.
-
A new era for patient services?
We have already spoken with companies working in rheumatology, oncology and dermatology that are investigating options for enabling these shifts, and industry can be more proactive in finding viable solutions for
-
Staying ahead in the era of precision medicine
It’s revolutionary and it’s evolutionary.”. While it is most advanced in oncology, precision medicine has wider, exciting applications beyond oncology and late-stage disease, such as rheumatology, and rare
-
NHS regional footprints
For example, the CCG has contracted services for musculoskeletal disorders (MSK), from the Nottinghamshire Integrated Care Partnership (ICP), which is now delivering services around rheumatology, arthritis, physiotherapy, imaging, primary care
-
Case study: From Clinical Trials to Real-World Evidence
on Product X’s real-world experience and heritage within dermatology and rheumatology, since these diseases share a common inflammatory mediator targeted by Product X.
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
New hires at EMA, Gilead and BeiGene
Raitt professor of medicine and clinical chief in the division of immunology and rheumatology.
-
Amgen appoints senior VP and head of the European region
Merck Serono, where she was senior VP of strategy and global marketing for neurology, rheumatology and immunology.
-
Bone Therapeutics looks to Pfizer for clinical head
Heynen is a specialist in rheumatology and immunology, with over 35 years of experience in medical and regulatory affairs at local, regional and international levels.
-
Aurora expands its team with three new hires
Mosley (pictured above right) joins the London agency as senior account director and arrives from Tonic Life Communications, where she worked across a number of therapeutic areas including rheumatology, respiratory and
-
Genentech’s Sunil Agarwal joins rare disease firm
He spent just over 10 years at Genentech where his positions included senior VP for immunology and infectious diseases and VP for rheumatology.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Covid-19: how is it affecting prescribing patterns?
Theoretically, the system should have more money to spend as there should be cost savings and this may open up opportunities to invest elsewhere in the rheumatology pathway, or maybe elsewhere
-
Welcoming the latest member of the Porterhouse Medical Advisory Group
Jess recently joined Porterhouse as an Associate Medical Writer. She has a medical degree from the University of Liverpool and worked in a variety of specialties, including paediatric rheumatology, diabetes and
-
RWE Blog 3: Is real-world evidence the holy grail
Examples include reviews specific to a therapeutic area, such asor rheumatology, which describe RWE findings and contrast them with RCT predictions.
-
Lucid Group supercharges its client services team with four spellbinding new hires
Kristen has worked on a wide variety of educational initiatives in various therapeutic areas, including dermatology, rheumatology, and the rare disease space. “I am so excited to be joining such a
-
Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK
Hazel Urwin joins Lucid Partners as a Scientific Director. Hazel has eight years’ experience in medical communications with particular expertise in the fields of neurology, immunology and rheumatology.
More from PMHub
Approximately 2 fully matching, plus 19 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
-
Account Management
-
Competitive Salary Offered
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Virtual congresses: video thrilled the cardio tsar
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
